Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
earth1d
Human brains hold dormant viruses that come to life if you hit your head
The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...
Common injury may trigger Alzheimer’s disease by awakening hidden virus, study warns
Inflammation in the brain can reawaken dormant viruses, which may lead to the onset of neurodegenerative disease, a new study finds. New research has shown for the first time that repeated head ...
Breakthrough as scientists believe anti ageing vaccine ‘closer than ever’
Imagine a world where the mind remains sharp, even as the years pass by. Scientists are on the brink of a breakthrough that ...
Central Nervous System (CNS) Therapeutics Market Forecast (2025-2035) by Disease, Drug Class, Distribution Channel and Region
Roche Holding, Novartis, and Eli Lilly & Company Dominate the Competitive Landscape Global Central Nervous System ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
The Victoria Advocate2d
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Building on decades of the Company's Alzheimer's research, two differentiated investigational therapies aim to slow ...
News Medical2d
Concussions may trigger Alzheimer's symptoms through latent viruses
Concussions and repetitive head trauma in sports like football and boxing, once accepted as an unpleasant consequence of ...
Science Daily3d
Study shows head trauma may activate latent viruses, leading to neurodegeneration
Researchers have uncovered mechanisms that may link head injuries and concussions to the emergence of neurodegenerative disease, pointing to latent viruses lurking in most of our brains that may be ...
Neuroscience News3d
Head Trauma May Reactivate Dormant Viruses, Increasing Alzheimer’s Risk
New research suggests that concussions and repetitive head trauma may reactivate dormant viruses like HSV-1 in the brain, potentially triggering neurodegenerative diseases such as Alzheimer’s.